FdaApplication
ANDA 205447
Identifiers
- fda_app_no: ANDA205447
Properties
| Property | Value |
|---|---|
| applicant_name | BRECKENRIDGE PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2023-02-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 100MG/VIAL | POWDER;INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 25MG/VIAL | POWDER;INTRAVENOUS |
2 products